| Line Item | 2025-03-29 | Y/Y |
|---|---|---|
| Revenue | $3.72B | -1.3% |
| Cost of Revenue | $2.18B | -4.3% |
| Gross Profit | $1.54B | +3.2% |
| R&D Expense | $747.7M | +9.6% |
| SG&A Expense | $171.7M | -55.9% |
| Operating Income | $95.5M | +4.2% |
| Interest Expense | $78.3M | +13.1% |
| Pre-tax Income | $65.9M | -10.4% |
| Income Tax | $10.3M |
| Line Item | 2025-03-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.02B | -0.8% |
| Accounts Receivable | $386.7M | -6.4% |
| Inventory | $641.0M | -9.8% |
| Current Assets | $2.17B | -11.4% |
| Total Assets | $5.93B | -9.5% |
| Current Liabilities | $783.2M | -36.3% |
| Long-term Debt | $1.55B | -0.0% |
| Line Item | 2025-03-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | $622.2M | -25.3% |
| Capital Expenditures | $137.6M | +8.2% |
| Investing Cash Flow | $36.6M | +126.8% |
| Financing Cash Flow | -$684.4M | -48.9% |
| Free Cash Flow | $484.6M | -31.4% |
| -92.9% |
| Net Income | $55.6M | +179.1% |
| EPS (Basic) | $0.59 | +181.9% |
| EPS (Diluted) | $0.58 | +180.6% |
| Total Liabilities |
| $2.54B |
| -15.3% |
| Stockholders' Equity | $3.39B | -4.6% |